| Literature DB >> 34026863 |
Nicky G F M Beukers1, Naichuan Su2,3, Bruno G Loos1, Geert J M G van der Heijden2,3.
Abstract
Tooth loss reflects the endpoint of two major dental diseases: dental caries and periodontitis. These comprise 2% of the global burden of human diseases. A lower number of teeth has been associated with various systemic diseases, in particular, atherosclerotic cardiovascular diseases (ACVD). The aim was to summarize the evidence of tooth loss related to the risk for ACVD or death. Cohort studies with prospective follow-up data were retrieved from Medline-PubMed and EMBASE. Following the PRISMA guidelines, two reviewers independently selected articles, assessed the risk of bias, and extracted data on the number of teeth (tooth loss; exposure) and ACVD-related events and all-cause mortality (ACM) (outcome). A total of 75 articles were included of which 44 were qualified for meta-analysis. A lower number of teeth was related to a higher outcome risk; the pooled risk ratio (RR) for the cumulative incidence of ACVD ranged from 1.69 to 2.93, and for the cumulative incidence of ACM, the RR ranged from 1.76 to 2.27. The pooled multiple adjusted hazard ratio (HR) for the incidence density of ACVD ranged from 1.02 to 1.21, and for the incidence density of ACM, the HR ranged from 1.02 to 1.30. This systematic review and meta-analyses of survival data show that a lower number of teeth is a risk factor for both ACVD and death. Health care professionals should use this information to inform their patients and increase awareness on the importance of good dental health and increase efforts to prevent tooth loss.Entities:
Keywords: atherosclerosis; cardiovascular disease; meta-analysis; mortality; number of teeth; risk; systematic review; tooth loss
Year: 2021 PMID: 34026863 PMCID: PMC8138430 DOI: 10.3389/fcvm.2021.621626
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Flow diagram of the study selection process.
Main characteristics of the included studies (N = 75).
| Abnet et al. ( | China | 28,790 | 45/55 | 40–69 | 15 | Clinical exam | ACM + ACVD | Clinical exam by village doctors | Unknown | High | |
| Adolph et al. ( | France | 76,188 | 64/36 | 16–89 | Mean: 3.4 (SD = 2.4) | Clinical exam | ACM | Death certificates | Present, excluded | High | |
| Aida et al. ( | Japan | 4,425 | 49/51 | ≥65 | 5 | Self-reported | ACVD | Death register | Present, adjusted | High | |
| Ajwani et al. ( | Finland | 364 | 28/72 | 76, 81, or 86 | 10 | Clinical exam | ACM + ACVD | Death register | Present, adjusted | Low | |
| Ajwani et al. ( | Finland | 175 | 31/69 | 76, 81, or 86 | 5 | Clinical exam | ACM + ACVD | Death register | Present, adjusted | High | |
| Ando et al. ( | Japan | 7,779 | Only men | 40–79 | 7 | Self-reported | ACM + ACVD | Register sheets at local government offices and death certificates | Present, excluded | High | |
| Ansai et al. ( | Japan | 697 | 40/60 | 80 | 6 | Clinical exam | ACM | Registers at the Public Health Centers | Present, no adjustment or exclusion | High | |
| Batty et et al. ( | Korea | 975,685 | 64/36 | Mean: | 21 | Clinical exam | CHD | CHD | Death certificates and health insurance claims | Present, excluded | High |
| Brown et al. ( | USA | 41,000 | 53/47 | ≥18 | 16 | Self-reported | ACM + ACVD | Death register | Present, adjusted | High | |
| Cabrera et al. ( | Sweden | 1,462 | Only women | 38, 46, 50, 54, 60 | 24 | Clinical exam | ACM + ACVD | ACVD | Death certificates and self-reported history and medical exam | Present, no adjustment or exclusion | High |
| Caplan et al. ( | USA | 535 | 30/70 | 60–103 | 7 | Clinical exam | ACM | Death certificates | Unknown | Low | |
| Chang et al. ( | Korea | 161,286 | 61/39 | 40–79 | Median: 10.5 | Clinical exam | Heart failure | Medical records | Present, excluded | High | |
| Chang et al. ( | Korea | 206,602 | 59/61 | 40–79 | Median: 10.4 | Clinical exam | Stroke | Medical records | Present, excluded | High | |
| Choe et al. ( | Korea | 867,256 | 78/22 | ≥30 | 14 | Clinical exam | Stroke | Stroke | Health insurance claims and death certificates | Present, excluded | High |
| Darnaud et al. ( | France | 85,830 | 61/39 | 16–94 | 14 | Clinical exam | ACM +ACVD | Death register and death certificates | Present, excluded | High | |
| Del Brutto et al. ( | Ecuador | 718 | 44/56 | ≥40 | 4 | Clinical exam | Stroke | Stroke | Death certificates and questionnaire and confirmation diagnosis by certified neurologists | Present, excluded | High |
| Dewake et al. ( | Japan | 173 | 14/86 | 62–102 | 1 | Clinical exam | ACM | Medical records | Unknown | High | |
| Dietrich et al. ( | USA | 1,203 | Only men | 21–84 | 35 | Clinical exam | ACVD | ACVD | Medical records and medical exam | Present, excluded | High |
| Fukai et al. ( | Japan | 5,688 | 40/60 | >40 | 15 | Clinical exam | ACM + ACVD | Public health center register | Present, excluded | High | |
| Furuta et al. ( | Japan | 281 | 25/75 | ≥65 | 3 | Clinical exam | ACM | Home-based care support centers | Unknown | High | |
| Garcia et al. ( | USA | 804 | Only men | 25–85 | 28 | Clinical exam | ACM | Death certificates | Present, excluded | High | |
| Goto et al. ( | Japan | 11,273 | 44/66 | 45–79 | 11 | Self-reported | ACM + ACVD | Death certificates | Present, excluded | High | |
| Hamalainen et al. ( | Finland | 226 | 29/71 | 80 | 10 | Clinical exam | ACM | Death register | Present, adjusted | High | |
| Hayasaka et al. ( | Japan | 21,730 | 42/58 | ≥65 | 4 | Self-reported | ACM | Death register | Present, adjusted | High | |
| Heitmann et al. ( | Denmark | 2,932 | 50/50 | Unknown | 12 | Clinical exam | ACVD | ACVD | Death register, national patient registry of hospital discharges and central person register | Present, excluded | High |
| Hiratsuka et al. ( | Japan | 891 | 46/54 | ≥70 | 13 | Clinical exam | ACM | Death register | Unknown | High | |
| Hirotomi et al. ( | Japan | 569 | 51/49 | 70 | 5 | Clinical exam | ACM | Unknown | Present, adjusted | High | |
| Hoke et al. ( | Austria | 411 | 66/34 | Median: 69 (IQR: 62–76) | Median: 6.2 (IQR: 5.8 – 6.6) | Clinical exam of edentulism | ACM + ACVD | Death register | Present, excluded and adjusted | High | |
| Holm-Pedersen et al. ( | Denmark | 573 | 48/52 | 70 | 20 | Clinical exam | ACM | Death register | Present, adjusted | High | |
| Holmlund et al. ( | Sweden | 7,674 | 43/57 | 20–89 | Median: 12 (IQR 0.2–29) | Clinical exam | ACM + ACVD | Death register | Present, adjusted | High | |
| Holmlund et al. ( | Sweden | 8,999 | 43/57 | 20–85 | 33 | Clinical exam | ACM | Death register | Present, excluded | High | |
| Hu et al. ( | Taiwan | 55,651 | 47/53 | ≥65 | 5 | Clinical exam | ACM | Death register | Unknown | High | |
| Hung et al. ( | USA | HPFS: 41,407 | 41/59 | HPFS: 40–75 | 12 | Self-reported | CHD | CHD | Medical records, hospital records, autopsy reports and death certificates | Present, excluded | High |
| Hung et al. ( | USA | 45,094 | Only men | 40–75 | 12 | Self-reported | PAD | Questionnaires and confirmed by medical records if possible | Present, excluded | High | |
| Iwasaki et al. ( | Japan | 273 | 50/50 | 80 | 3 | Clinical exam | Stroke | Stroke-related costs and hospitalization obtained by health insurance claims | Present, excluded and adjusted | Low | |
| Janket et al. ( | Finland | 473 | 63/37 | Unknown | Median: 15.8 | Clinical exam | ACM + ACVD | Death register | Present, no adjustment or exclusion | High | |
| Janket et al. ( | Finland | 461 | 63/37 | Unknown | Median: 15.8 | Clinical exam | ACVD | Death register | Present, no adjustment or exclusion | High | |
| Joshipura et al. ( | USA | 41,380 | Only men | 40–75 | 12 | Self-reported | Stroke | Medical records | Present, excluded | High | |
| Joshipura et al. ( | USA | 44,119 | Only men | 40–75 | 6 | Self-reported | CHD | CHD | Medical records | Present, excluded | High |
| Joshy et al. ( | Australia | 167,697 | 43/57 | 45–75 | 5 | Self-reported | ACM | ACVD | Death register and medical records | Present, excluded | High |
| Kebede et al. ( | Germany | 3,327 | Only men | 20–81 | 14 | Clinical exam | ACM + ACVD | Death register | Unknown | High | |
| Kim et al. ( | USA | 588 | 49/51 | ≥40 | 7 | Clinical exam | ACM | Death register | Present, adjusted | High | |
| LaMonte et al. ( | USA | 57,001 | Only women | 50–79 | 12 | Self-reported | ACM + ACVD | ACVD, CHD, Stroke | Annual mailed follow-up questionnaires and medical record review | Present, excluded | High |
| Lee et al. ( | Korea | 4,440,970 | 62/38 | Mean 41.5 | 9 | Clinical exam | ACM | MI, Stroke, Heart Failure | Death register and health check-ups | Present, excluded | High |
| Li et al. ( | USA | 10,958 | 58/42 | 55–88 | 5 | Clinical exam | ACM + ACVD | ACVD | Certification, autopsy report, clinical notes and medical exam | Present, adjusted | High |
| Liljestrand et al. ( | Finland | 7,629 | 49/51 | 25–74 | 13 | Clinical exam | ACM | ACVD | Death register and drug reimbursement records and hospital discharge register | Present, adjusted | High |
| Matsuyama et al. ( | Japan | 77,397 | 47/53 | >65 | 1,374 days | Self-reported | ACM | Death register | Unknown | High | |
| Morita et al. ( | Japan | 59 patients ≥20 teeth, 59 matched patients <20 teeth | 41/59 | ≥80 | 10 | Self-reported | ACM | Death register | Present, no adjustment or exclusion | High | |
| Morrison et al. ( | Canada | 9,331 (CHD), 10,120 (ACVD) | 46/54 | 35–84 | 23 | Clinical exam | CHD + ACVD | Death register | Present, excluded | Unknown | |
| Mucci et al. ( | USA | 15,273 twins | Unknown | 35 | 37 | Self-reported | ACVD | ACVD | Death register and medical records | Present, excluded | High |
| Munoz-Torres et al. ( | USA | 79,663 | Only women | Mean age per category number of teeth | 16 | Self-reported | PAD | Self-reported and confirmed by medical records | Present, excluded | High | |
| Noguchi et al. ( | Japan | 3,081 | Only men | 36–59 | 5 | Self-reported | MI | Self-reported | Present, excluded | Low | |
| Nomura et al. ( | Japan | 608 | 38/62 | 80 | 20 | Clinical exam | ACM | Death register | Unknown | High | |
| Oluwagbemigun et al. ( | Germany | 24,313 | 38/62 | 35–64 | 13 | Self-reported | MI + stroke | Self-reported and validated by medical records | Present, adjusted | High | |
| Österberg et al. ( | Denmark, Finland, Sweden | 1,004 | 43/57 | 75 | 7 | Self-reported | ACM | Death register | Present, adjusted | High | |
| Österberg et al. ( | Sweden | 1,803 | 47/53 | 70 | 18 | Clinical exam | ACM | Death register | Present, adjusted | Low | |
| Padilha et al. ( | USA | 500 | 82/18 | Mean: 58 (±17) | 26 | Clinical exam | ACM | Telephone follow-up, correspondence from relatives, and annual searches of death register | Present, adjusted | High | |
| Paganini-Hill et al. ( | USA | 5,611 | 31/69 | 52–105 | 17 | Self-reported | ACM | Death register and death certificates | Present, adjusted | High | |
| Park et al. ( | Korea | 247,696 | 58/42 | 46–60 | 10 | Clinical exam | ACVD | Death register and death certificates | Present, excluded | High | |
| Qi et al. ( | China | 1,385 | 48/52 | >75 | 4 | Clinical exam | ACM + ACVD | Death register | Unknown | High | |
| Ragnarsson et al. ( | Iceland | 2,613 | 47/53 | 25–79 | ACM: 15 | Clinical exam | ACM + CHD | Death register | Unknown | High | |
| Reichert et al. ( | Germany | 942 | 74/26 | ≥18 | 1 | Clinical exam | Combined endpoint | Combined endpoint | Questionnaire, telephone interview, civil registration offices, medical records | Present, no adjustment or exclusion | High |
| Reichert et al. ( | Germany | 953 | 74/26 | ≥18 | 3 | Clinical exam | Combined endpoint | Combined endpoint | Civil registration offices, medical records, physicians and relatives | Present, no adjustment or exclusion | High |
| Saito et al. ( | Japan | 4,700 | 45/55 | 75 and 80 | 2 | Clinical exam | ACVD | Health insurance claims | Present, no adjustment or exclusion | High | |
| Schwahn et al. ( | Germany | 1,803 | 50/50 | Median: 64 (IQR: 17) | 12 | Clinical exam | ACM + ACVD | Death certificates | Unknown | High | |
| Shimazaki et al. ( | Japan | 1,762 | 28/72 | 59–107 | 6 | Clinical exam | ACM | Medical records or interviews with study participants' relatives | Present, adjusted | Low | |
| Soikkonen et al. ( | Finland | 292 | 29/71 | 76, 81, and 86 | 4 | Clinical exam | ACM | Unknown | Unknown | High | |
| Tu et al. ( | UK | 10,592 | 78/22 | ≤30 | 57 | Clinical exam | ACM + ACVD + CHD + Stroke | Death register | Unknown | High | |
| Tuominen et al. ( | Finland | 6,527 | 47/53 | 30–69 | Mean: 12 | Clinical exam | ACM + CHD | Death register | Unknown | High | |
| Vedin et al. ( | 39 Countries on 5 Continents | 15,456 | 81/19 | ≥60 | Median: 3.7 | Self-reported | Primary outcome | Primary outcome | Medical records and medical exam | Present, adjusted | High |
| Vedin et al. ( | 39 Countries on 5 Continents | 15,456 | 81/19 | ≥60 | Median: 3.7 | Self-reported | Primary outcome | Primary outcome | Medical records and medical exam | Present, adjusted | High |
| Vogtmann et al. ( | Iran | 50,023 | 42/58 | 40–75 | 10 | Self-reported | ACM + ACVD | Interview | Present, excluded | High | |
| Watt et al. ( | UK | 12,871 | 44/56 | ≥35 | 12 | Self-reported | ACM + ACVD + CHD + Stroke | Clinical exam and death certificate | Unknown | High | |
| Wu et al. ( | USA | 9,962 | 48/52 | 25–74 | 21 | Clinical exam | CVA | CVA | Death certificates and medical records | Present, excluded | High |
| Yuan et al. ( | China | 36,153 | 41/59 | Median: 90 (IQR: 81–99) | Median: 3 (IQR: 1.6–5.7) | Self-reported | ACM | Interview with close family-member | Present, adjusted | High | |
ACM, all-cause mortality; ACVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; MI, myocardial infarction; CVA, cerebrovascular accident; PAD, peripheral arterial disease; HPFS, Health Professionals Follow-up Study; NHS, Nurses' Health Study.
All studies (n = 75) use as statistical analysis Cox proportional hazard regression model, except for the following studies: Ansai et al. (.
The reported age range applies to the baseline examination.
The reported follow-up time is the maximum time in years if reported.
The follow-up rate was classified into two categories: (1) low follow-up rate (<80%) and (2) high follow-up rate (≥80%).
Combined endpoint: MI and stroke/TIA, cardiac-related and stroke-related mortality.
Primary outcome: Major Adverse Cardiovascular Events (MACEs) including a composite of the first occurrence of ACVD death, non-fatal MI, or non-fatal stroke.
Secondary outcome: Non-fatal or fatal MI; Non-fatal or fatal stroke; ACVD death; ACM.
The percentage male/female applies to the included number of study participants.
The percentage male/female is based on the outcome for CHD.
The cohort consists of study participants with prevalent atherosclerotic carotid artery disease, as defined by the presence of non-stenotic plaque or carotid stenosis of any degree. Patients with an ACVD-event (MI/stroke/coronary revascularization/peripheral vascular surgery) during the preceding 6 months were excluded. For history of MI, PAD, history of stroke, baseline degree of carotid stenosis, adjustment in the analyses were performed.
In a subgroup analysis performed in 4,164 study participants in whom a history of previous MI and hypertension (drug-treated) was collected, the relationship between the number of teeth and future ACVD death was essentially unaltered compared to the analysis in the total sample when previous MI and hypertension were added as confounders in the analysis.
Baseline data consisted of 256 coronary artery disease patients and 250 age and sex-matched controls and created a prospective follow-up study.
Known CHD is in the inclusion criteria.
Patients were eligible to participate if they had CHD, but the target patients of this paper are the patients with stable CHD. In the statistical analyses, correction for ACVD was done.
Figure 2(A) Forest plots for meta-analysis of cumulative incidence for categorical data of the number of teeth, ACVD, and all-cause mortality. (B) Forest plots for meta-analysis of incidence density for categorical data of the number of teeth, atherosclerotic cardiovascular disease (ACVD) and all-cause mortality. (C) Forest plots for meta-analysis of incidence density for continuous data of the number of teeth, ACVD, and all-cause mortality. ACVD, Atherosclerotic Cardiovascular Disease; vs., versus; ref., reference group; Ne, number of events; Nt, number of total included study participants; N.A., Not Applicable. The Hazard Ratio (HR) in the Forest Plot which was based only on one study, was obtained directly from the included study.